TITLE

Beneficial Effects of Quercetin on Obesity and Diabetes

AUTHOR(S)
Aguirre, Leixuri; Arias, Noemi; Macarulla, M. Teresa; Gracia, Ana; Portillo, Maria P.
PUB. DATE
January 2011
SOURCE
Open Nutraceuticals Journal;2011, Vol. 4, p189
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Scientific research is constantly looking for new molecules that could be used as dietary functional ingredients in the fight against obesity and diabetes, two pathologies highly prevalent in Western societies. In this context, flavonoids represent a group of molecules of increasing interest. The major flavonoid is Quercetin, which belongs to the class called flavonols and is mainly found in apples, tea, onions, nuts, berries, cauliflower, cabbage and many other foods. It exhibits a wide range of biological functions including anticarcenogenic, anti-inflammatory and antiviral; it also inhibits lipid peroxidation, platelet aggregation and capillary permeability. This review focuses on the main effects of Quercetin on obesity and diabetes. The mechanisms of action explaining the effects of Quercetin on these two metabolic disturbances are also considered. Good perspectives have been opened for Quercetin, according to the results obtained either in cell cultures or in animal models. Nevertheless, further studies are needed to better characterize the mechanisms of action underlying the beneficial effects of this flavonoid on these pathologies. Moreover, the body fat-lowering effect and the improvement of glucose homeostasis need to be confirmed in humans. Animal studies have consistently failed to demonstrate adverse effects caused by Quercetin. In contrast, due to inhibitory effect of Quercetin in cytochrome P450, interactions with drugs can be taken into account when they are administered at the same time than Quercetin.
ACCESSION #
70497791

 

Related Articles

  • Production of 3- O-xylosyl quercetin in Escherichia coli. Pandey, Ramesh; Malla, Sailesh; Simkhada, Dinesh; Kim, Byung-Gee; Sohng, Jae // Applied Microbiology & Biotechnology;Mar2013, Vol. 97 Issue 5, p1889 

    Quercetin, a flavonol aglycone, is one of the most abundant flavonoids with high medicinal value. The bioavailability and pharmacokinetic properties of quercetin are influenced by the type of sugars attached to the molecule. To efficiently diversify the therapeutic uses of quercetin, Escherichia...

  • P034 - PROTECTIVE EFFECT OF QUERCETIN ON PROTEIN DAMAGE IN RATS WITH EXPERIMENTAL DIABETES. BÜYÜKBEN, Ahmet; KIRAL, Funda; SEKKIN, Selim // Turkish Journal of Biochemistry / Turk Biyokimya Dergisi;2012 Special Issue, Vol. 37 Issue S1, p175 

    No abstract available.

  • In this issue.  // Clinical Pharmacology & Therapeutics;May2007, Vol. 81 Issue 5, p613 

    The article discusses various reports published within the issue, including one on state-of-the-art treatment for diabetes and another on the treatment of obesity through lifestyle modification.

  • Innovation and Improvement in the Treatment of Obesity and Diabetes. Ryder, S. W. // Clinical Pharmacology & Therapeutics;May2007, Vol. 81 Issue 5, p615 

    The article discusses various reports published within the issue, including one on potential new targets for obesity pharmacotherapy,and another on development and use of treatments for the prevention of diabetes.

  • Flavonol 3-O-Glycosides from Three Algerian Bupleurum Species. Bencheraiet, Reguia; Kabouche, Ahmed; Kabouche, Zahia; Touzani, Rachid; Jay, Maurice // Records of Natural Products;2012, Vol. 6 Issue 2, p171 

    Flavonoids distribution in three algerian Bupleureum (Apiaceae) species has been investigated. Quercetin (1), quercetin 3-rutinoside (2) and isorhamnetin 3-rutinoside (3) were found in the endemic species B. plantagineum Desf. Three kaempferol glycosides, kaempferol 3-glucoside (4), kaempferol...

  • Powerful antibody-based strategy suggests a new therapeutic approach to diabetes and obesity.  // Biomedical Market Newsletter;9/30/2011, Vol. 21, p18 

    The article focuses on the powerful antibody-based strategy devised by a team at Cold Spring Harbor Laboratory (CSHL) in the U.S. as a therapeutic approach to diabetes and obesity.

  • Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob/ob mice treated with dopaminergic agonists. Scislowski, P W D; Tozzo, E; Zhang, Y; Phaneuf, S; Prevelige, R; Cincotta, A H // International Journal of Obesity & Related Metabolic Disorders;Apr1999, Vol. 23 Issue 4, p425 

    OBJECTIVE: We previously reported that a two week treatment with SKF 38393 (SKF, a dopamine D1 receptor agonist), plus bromocriptine (BC, a dopamine D2 receptor agonist) acted synergistically to normalize hyperphagia, body fat, hyperglycaemia and hyperlipidaemia in ob/ob mice. The present study...

  • Ayurvedic Herb for Weight Loss. Sodhi, Virender // Natural Health;Jul2001, Vol. 31 Issue 5, p42 

    Attempts to verify health claims attributed to Gymnem sylvestre, also known as gurmar. Use as treatment for diabetes and obesity; Ability of gurmar to double the number of cells in the pancreas that produce insulin; Stimulation of production of chemicals that help metabolize sugars, fats and...

  • Perspective of Small-Molecule AdipoR Agonist for Type 2 Diabetes and Short Life in Obesity. Okada-Iwabu, Miki; Kadowaki, Takashi; Iwabi, Masato; Yamauchi, Toshimasa; Ueki, Kohjiro // Diabetes & Metabolism Journal;Oct2015, Vol. 39 Issue 5, p363 

    Obesity associated with unhealthy diet and lack of exercise is shown to contribute to the onset and/or aggravation of the metabolic syndrome and diabetes, thus placing affected individuals at increased risk of cardiovascular disease and cancer. Plasma adiponectin levels are decreased in obesity,...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics